Company intelligence / Profile preview

Sequent Scientific

Mumbai, Maharashtra, India

Ownership: Private
Employees: ~1500
Development stage: Other

Overview

Sequent Scientific is a leading, global, commercial-stage animal health company with a focus on APIs and finished dosage formulations primarily for infectious diseases, pain management, and gut health in animals. It has received regulatory approvals (USFDA, EUGMP, WHO, TGA) and operates in over 90 countries with 7 manufacturing facilities. The company maintains strong growth in regulated and emerging markets, with a recent merger positioning it for further global expansion.

Therapeutic areas: GastroenterologyOtherInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Veterinary

Beyond the preview

Go deeper on Sequent Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sequent Scientific.

Explore the full profile